Key facts
- Synapse Health’s last known valuation is $322.0M (Dec 2024).
- It has raised $161.0M across 2 recorded rounds; the latest was Early Stage VC ($25.0M) in Sep 2023.
- Synapse Health has filed 2 Form Ds with the SEC, most recently Sep 2023 ($25.0M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Synapse Health
Funding rounds
2 roundsAbout Synapse Health
Developer of a digital-first platform designed to modernize the medical equipment and supply industry. The company offers EMR integration, real-time PPD tracking, online ordering, cost reduction, customer portal and inventory tools, and leverages technology to reduce cost and simplify the medical supply ordering experience for patients, providers, and health plans, enabling prescribers to focus on patients and not on paperwork.
- Sector
- Healthcare
- HQ
- Skokie, IL, United States
- Founded
- 2016
- Employees
- 77
- Website
- synapsehealth.com/
- Ownership
- Privately Held (backing)
Synapse Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synapse Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synapse Health in its N-PORT filings yet. We sweep new filings monthly.